Skip to Content


In the US, Desirudin (desirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Deep Vein Thrombosis, Prophylaxis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

Hirudin (Hirudo medicinalisisoform HV1), 63-desulfo-

Foreign Names

  • Desirudinum (Latin)
  • Desirudin (German)
  • Désirudine (French)
  • Desirudina (Spanish)

Generic Names

  • Desirudin (OS: BAN, USAN)
  • Désirudine (OS: DCF)
  • 63-Desulfohirudin (IS: WHO)
  • CGP 39393 (IS: Ciba-Geigy)

Brand Names

  • Iprivask
    Marathon, United States
  • Revasc
    Aventis Pharma, Greece; Canyon, Spain; Canyon, Lithuania; Canyon, Portugal; Canyon Pharma, Germany; Novartis, Slovakia

International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.